Literature DB >> 16821054

[Urinary cytology. Possibilities, limitations and the future].

D Zaak1, S Tritschler, R Knuechel, F Vom Dorp, O W Hakenberg, S Hautmann, H Rübben.   

Abstract

Even now, 60 years after the fundamental studies on oncological urinary cytology carried out by Papanicolaou and Marschall and the subsequent integration of the test they devised into the diagnostic investigations applied in the diagnosis of urothelial carcinoma, urinary cytology still maintains its place in the diagnosis of primary and recurrent tumours of the urinary tract. Newer diagnostic techniques involving urine-bound tumour markers have not so far achieved such high levels of acceptance as their method. It is possible, certainly, that a combination of these newer methods with cytological testing, or with other innovative diagnostic methods, such as photodynamic techniques, could prove very promising in the future and might overcome the limitations of urinary cytology.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16821054     DOI: 10.1007/s00120-006-1115-6

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  22 in total

1.  The clinical implications of telomerase activity in upper tract urothelial cancer and washings.

Authors:  W J Wu; L T Liu; C N Huang; C H Huang; L L Chang
Journal:  BJU Int       Date:  2000-08       Impact factor: 5.588

2.  Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers.

Authors:  Tomonori Habuchi; Michael Marberger; Michael J Droller; George P Hemstreet; H Barton Grossman; Jack A Schalken; Bernd J Schmitz-Dräger; William M Murphy; Aldo V Bono; Peter Goebell; Robert H Getzenberg; Stefan H Hautmann; Edward Messing; Yves Fradet; Vinata B Lokeshwar
Journal:  Urology       Date:  2005-12       Impact factor: 2.649

3.  Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers.

Authors:  Vinata B Lokeshwar; Tomonori Habuchi; H Barton Grossman; William M Murphy; Stefan H Hautmann; George P Hemstreet; Aldo V Bono; Robert H Getzenberg; Peter Goebell; Bernd J Schmitz-Dräger; Jack A Schalken; Yves Fradet; Michael Marberger; Edward Messing; Michael J Droller
Journal:  Urology       Date:  2005-12       Impact factor: 2.649

4.  Upper urinary tract washing in the diagnosis of transitional cell carcinoma of the renal pelvis and calices. A comparison with voided urine.

Authors:  M Raica; O Mederle; I Ioiart
Journal:  Rom J Morphol Embryol       Date:  1995 Jul-Dec       Impact factor: 1.033

Review 5.  Contemporary management of the urethra in patients after radical cystectomy for bladder cancer.

Authors:  Peter E Clark; M Craig Hall
Journal:  Urol Clin North Am       Date:  2005-05       Impact factor: 2.241

6.  Significance of urinary cytology in the early detection of transitional cell cancer of the upper urinary tract.

Authors:  H Zincke; J J Aguilo; G M Farrow; D C Utz; A U Khan
Journal:  J Urol       Date:  1976-12       Impact factor: 7.450

7.  Urethral wash cytopathology for monitoring patients after cystoprostatectomy with urinary diversion.

Authors:  Jacquelyn A Knapik; William M Murphy
Journal:  Cancer       Date:  2003-12-25       Impact factor: 6.860

8.  Endoscopic management of upper urinary tract transitional cell carcinoma: long-term experience.

Authors:  Siamak Daneshmand; Marcus L Quek; Jeffry L Huffman
Journal:  Cancer       Date:  2003-07-01       Impact factor: 6.860

9.  Value of urethral wash cytology in the retained male urethra after radical cystoprostatectomy.

Authors:  Daniel W Lin; Harry W Herr; Guido Dalbagni
Journal:  J Urol       Date:  2003-03       Impact factor: 7.450

10.  Positive urinary cytology following a complete response to intravesical bacillus Calmette-Guerin therapy: pattern of recurrence.

Authors:  M D Schwalb; H W Herr; P C Sogani; P Russo; J Sheinfeld; W R Fair
Journal:  J Urol       Date:  1994-08       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.